ALTO-207 in Adults With Treatment-resistant Depression (TRD)

NCT07553637 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

178

Enrollment

INDUSTRY

Sponsor class

Conditions

Treatment-resistant Depression (TRD)

Interventions

DRUG: ALTO-207
DRUG: Placebo

Sponsor

Alto Neuroscience